Mi-Jung Kim
- Oncology top 10%
- Cancer Research top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Infectious Diseases top 10%
- Topics
- Breast Cancer Treatment Studies (5 papers)HER2/EGFR in Cancer Research (3 papers)Sarcoma Diagnosis and Treatment (3 papers)
- Cited by
- Cancer ResearchOncologyDermatology
- Partner nations
- South KoreaUnited StatesGhana
In The Last Decade
Mi-Jung Kim
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 109
- Oncology 349
- Cancer Research 317
- Molecular Biology 278
- Pathology and Forensic Medicine 209
- Infectious Diseases 164
Countries citing papers authored by Mi-Jung Kim
This map shows the geographic impact of Mi-Jung Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi-Jung Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi-Jung Kim more than expected).
Fields of papers citing papers by Mi-Jung Kim
This network shows the impact of papers produced by Mi-Jung Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi-Jung Kim. The network helps show where Mi-Jung Kim may publish in the future.
Co-authorship network of co-authors of Mi-Jung Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Mi-Jung Kim. A scholar is included among the top collaborators of Mi-Jung Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi-Jung Kim. Mi-Jung Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 40 | |
| 3 | 268 | |
| 4 | 12 | |
| 5 | 5 | |
| 6 | 80 | |
| 7 | 4 | |
| 8 | 19 | |
| 9 | 1 | |
| 10 | 8 | |
| 11 | 18 | |
| 12 | 43 | |
| 13 | 8 | |
| 14 | 87 | |
| 15 | 293 | |
| 16 | 53 | |
| 17 | 13 | |
| 18 | 2 | |
| 19 | 46 | |
| 20 | 12 |
About Mi-Jung Kim
Mi-Jung Kim is a scholar working on Cancer Research, Pathology and Forensic Medicine and Software, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (317 citations), Oncology (349 citations) and Dermatology (103 citations). Mi-Jung Kim has collaborated with scholars based in South Korea, United States and Ghana. Frequent co-authors include Gyungyub Gong, Jae Y. Ro, Hak Hee Kim, Sung‐Bae Kim, Sei-Hyun Ahn, Seung Won, Jiwon Jung, Sung‐Han Kim, Soohyun Bae and Ji-Hoon Lee. Their work appears in journals such as Bioinformatics, Biochemical and Biophysical Research Communications and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.